TUSAMITAMAB RAVTANSINE

UNII:	DSS3BE2ZXN
Formula:
Preferred Substance Name:	TUSAMITAMAB RAVTANSINE

2254086-60-5
IMMUNOGLOBULIN G1, ANTI-(HUMAN CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5) (HUMAN MONOCLONAL SAR408377 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL SAR408377 .KAPPA.-CHAIN, DIMER, AMIDE WITH N2'-(4-((3-CARBOXYPROPYL)DITHIO)-4-METHYL-1-OXOPENTYL)-N2'-DEACETYLMAYTANSINE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 5 (CARCINOEMBRYONIC ANTIGEN, MECONIUM ANTIGEN 100, ANTIGEN_CD66E)) HUMANIZED MOUSE MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-449) (VH(MUS MUSCULUS IGHV5-12-1*01 (87%)-(IGHD)-IGHJ3*01 (93%)/HOMO SAPIENS IGHV3-23*01 (77%) IGHJ4*01 (93%)) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*01 (CH3(K107>DEL(450))) (121-449) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (MUS MUSCULUS IGKV12-44*01 (87%)-IGKJ4*01/HOMO SAPIENS IGKV1-39*01 (82%)-IGKJ2*02 (91%))(6.3.9) (1'-107') HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA; 3 OR 4 (N) LYSINES ARE N6 SUBSTITUTED BY RAVTANSINE
MAYTANSIN-LOADED ANTI-CEACAM5 MAB
SAR408701
SAR-408701
TUSAMITAMAB RAVTANSINE [INN]
TUSAMITAMAB RAVTANSINE [USAN]
TUSAMITAMAB RAVTANSINE [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TUSAMITAMAB RAVTANSINE

Synonyms and Mappings

Resources